Abstract
The purpose of this study was to investigate the in vitro antibacterial effects of three different carbamide peroxide products (Nitewhite, Opalescence, and Proxigel) on cariogenic microorganisms (mutans streptococci [MS] and lactobacilli), and to evaluate the effects of a 10% carbamide peroxide solution (Proxigel) on salivary levels of MS and lactobacilli clinically. Growth inhibition studies were performed to determine the concentration and exposure time of carbamide peroxide to give total inhibition of recoverable growth of MS and lactobacilli. Paraffin-stimulated saliva samples were collected from subjects before and after 6 weeks of treatment with 10% carbamide peroxide in bleaching trays, and levels of MS and lactobacilli were determined. The growth inhibition studies showed no visible growth of MS or lactobacilli at 24-, 48-, or 72-hour incubation, after a 2-hour exposure to 1% carbamide peroxide. Identical results were obtained with all three carbamide peroxide products. In the clinical study, the mean salivary MS levels, expressed as logarithm colony-forming units per milliliter (CFU/mL), were 5.38 for the pretreatment samples and 5.23 for the post-treatment samples. The differences were not statistically significant (p > .05). However, there was a reduction in logarithm lactobacilli counts from a mean of 4.12 pretreatment to a mean of 2.74 post-treatment. This was statistically significant (p < .05).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have